Cash conversion remains structurally disconnected, as evidenced by a negative operating cash flow of $6.7 million in 2026Q1 despite a net loss of $8.3 million.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|
| Cash from Operations | -1.11M | -11.22M | 5.91M | -3.23M | -37.53M | 23.63M | 37.01M | 40.59M | 59.98M | 60.49M | 31.03M | 38.16M | 15.7M | 13.47M | 4M | 1.86M |
| Operating CF Margin % | - | -3.22% | 1.76% | -1.02% | -9.95% | 6.6% | 12% | 11.22% | 16.75% | 24.25% | 15.3% | 24% | 13.95% | 17.85% | 8.24% | 6.07% |
| Operating CF Growth % | 24.96% | -289.65% | 282.87% | 91.38% | -258.81% | -36.15% | -8.82% | -32.32% | -0.85% | 94.93% | -18.68% | 143.11% | 16.56% | 236.34% | 115.38% | - |
| Net Income | -24.9M | -22.75M | -35.89M | -102.45M | -83.77M | -6.33M | -5.83M | 20.95M | 51.84M | 21M | 20.52M | 11.59M | 6.83M | 25.43M | 564K | -2M |
| Depreciation & Amortization | 20.37M | 20.66M | 21M | 18.15M | 23.51M | 21.63M | 18.58M | 13.83M | 11.29M | 12.3M | 13.56M | 14.01M | 12.08M | 8.54M | 4.98M | 3.2M |
| Stock-Based Compensation | 5.87M | 8.01M | 7.4M | 7.43M | 12.28M | 10.94M | 8.2M | 9.13M | 12.79M | 9.64M | 7.29M | 3.64M | 1.45M | 230K | 60K | 144K |
| Deferred Taxes | -1.6M | -1.1M | -1.15M | -251K | 0 | 14.44M | -82K | 2.87M | -11.6M | 7.95M | 1.04M | 4.76M | 1.56M | -21.79M | 3K | 0 |
| Other Non-Cash Items | 13.02M | 10.87M | 18.94M | 59.62M | 55.16M | 3.02M | 16.17M | 21.69M | 21.29M | 20.24M | 22.92M | 19.09M | 13.46M | 11.09M | 1.27M | 3.72M |
| Working Capital Changes | -13.88M | -26.91M | -4.39M | 14.27M | -44.72M | -20.07M | -31K | -27.89M | -25.65M | -10.64M | -34.3M | -14.92M | -19.69M | -10.04M | -2.87M | -3.2M |
| Change in Receivables | -11.95M | -14.62M | -5.07M | 11.13M | -51.62M | -5.42M | -7.25M | -17.03M | -25.96M | -18.26M | -32.74M | -16.7M | -22.16M | -13.63M | -3.76M | -4.06M |
| Change in Inventory | -4.11M | -3.21M | -3.54M | 7.88M | -5.6M | -10.78M | 7.59M | -10.34M | -9.97M | -5.89M | -7.46M | -2.57M | -3.57M | -267K | -2.44M | 109K |
| Change in Payables | -2.63M | 5.6M | -3.41M | -9.18M | 6.76M | -6.48M | -5.83M | 3.2M | 6.36M | 7.44M | -86K | 1.58M | 3.64M | 2.15M | 2.6M | 340K |
| Cash from Investing | -26.15M | -26.21M | -13.97M | -59.31M | -10.88M | -14.64M | -25.64M | -44.06M | -24.96M | -24.43M | -11.93M | -29.3M | -16.25M | -18.14M | -12.47M | -8.92M |
| Capital Expenditures | -9.13M | -10.38M | 0 | -27.01M | -21.22M | -24.07M | -17.6M | -6.26M | -12.97M | -10.23M | -8.02M | -12.49M | -16.24M | -18.14M | -12.45M | -8.96M |
| CapEx % of Revenue | 2.6% | 2.98% | 5.09% | 8.56% | 5.63% | 6.72% | 5.7% | 1.73% | 3.62% | 4.1% | 3.95% | 7.85% | 14.43% | 24.05% | 25.63% | 29.25% |
| Acquisitions | 0 | 0 | 0 | -29.43M | 331K | 153K | 163K | -70.4M | 350K | -4.49M | -113K | 45K | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -16.82M | 0 | 0 | 0 | 0 | -60K | 365K | 183K | 501K | -45K | -222K | -37K | -27K | 42K |
| Cash from Financing | -1.89M | 24.18M | 265K | 960K | 380K | 15M | 2.07M | 4.93M | 18.3M | 14M | 7.71M | 381K | 43.87M | 3.08M | 19.68M | 5.18M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -315K | -299K | -10.07M | 1.79M | -693K | 5.13M |
| Equity Issued (Net) | -1.02M | 28.18M | 811K | 1.48M | 1.74M | 15.65M | 2.42M | 0 | 0 | 0 | 0 | 0 | 51.89M | 0 | 19.95M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -1.87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -873K | -4M | -546K | -518K | -1.35M | -647K | -350K | 4.93M | 18.3M | 14M | 8.03M | 680K | 2.05M | 1.3M | 425K | 47K |
| Net Change in Cash | -28.13M | -12.4M | -8.08M | -61.52M | -48.51M | 23.56M | 13.93M | 1.4M | 53.68M | 50.1M | 26.75M | 9.27M | 43.31M | -1.59M | 11.21M | -1.88M |
| Free Cash Flow | -10.24M | -21.6M | -11.18M | -29.75M | -58.75M | -302K | 19.67M | 34.08M | 47M | 50.27M | 23.02M | 25.67M | -540K | -4.67M | -8.44M | -7.1M |
| FCF Margin % | -2.91% | -6.19% | -3.33% | -9.43% | -15.57% | -0.08% | 6.38% | 9.42% | 13.13% | 20.15% | 11.35% | 16.15% | -0.48% | -6.2% | -17.38% | -23.18% |
| FCF Growth % | 51.55% | -93.21% | 62.42% | 49.36% | -19354.97% | -101.54% | -42.28% | -27.5% | -6.49% | 118.38% | -10.34% | 4854.07% | 88.45% | 44.64% | -18.91% | - |
| FCF per Share | -0.37 | -0.79 | -0.47 | -1.28 | -2.57 | -0.01 | 0.89 | 1.53 | 2.09 | 2.30 | 1.09 | 1.24 | -0.03 | -0.26 | -0.52 | -0.43 |
| FCF Conversion (FCF/Net Income) | 0.41x | 0.49x | -0.16x | 0.03x | 0.45x | -3.73x | -6.35x | 1.94x | 1.16x | 2.88x | 1.51x | 3.29x | 2.30x | 0.53x | 7.10x | -0.93x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26K | 487K | 552K | 462K | 258K |
| Taxes Paid | 84K | 0 | 375K | 0 | 0 | 0 | 0 | 239K | 1.65M | 1.27M | 0 | 19K | 2.06M | 311K | 37K | 16K |
High customer acquisition costs
Based on reported financial statements, Inogen's operating cash flow frequently diverges from net income, with the company recording a net loss of $8.3 million in 2026Q1 while simultaneously reporting a negative operating cash flow of $6.7 million, highlighting a persistent inability to convert accounting earnings into cash.
The consistent gap between net income and operating cash flow suggests that the company's accrual-based losses are not merely accounting artifacts but reflect genuine cash outflows required to sustain operations. Investors should monitor whether the reliance on non-cash adjustments like depreciation and stock-based compensation masks a deeper structural issue in the company's core profitability.
As indicated by recent quarterly filings, Inogen's free cash flow trajectory remains highly erratic, swinging from a negative $18.8 million in 2025Q1 to a positive $64,000 in 2025Q3, which underscores the difficulty in achieving a sustainable cash-generative state within the current direct-to-consumer business model.
The lack of a clear upward trend in free cash flow suggests that the company's capital requirements for its rental fleet and marketing initiatives continue to outpace its ability to generate internal liquidity. This volatility warrants further investigation into whether the business can reach a self-funding inflection point without further dilutive financing.
According to the cash flow data, Inogen experienced a significant working capital drain of $21.3 million in 2025Q1, a development that suggests the company's cash management is highly sensitive to inventory build-ups and the timing of receivables collection within its complex distribution network.
The erratic nature of these working capital changes implies that the company may be struggling to optimize its inventory levels relative to fluctuating demand for its portable oxygen concentrators. Such fluctuations create unnecessary pressure on the balance sheet, potentially forcing management to prioritize short-term liquidity over long-term strategic investments.
Based on the provided figures, Inogen's capital expenditure as a percentage of revenue reached as high as 8.3% in 2023Q4, indicating that the company must continuously reinvest in its rental fleet and manufacturing capabilities just to maintain its current market position.
The persistent need for capital expenditure, even during periods of negative operating cash flow, suggests that the business model is inherently capital-intensive. This dynamic limits the company's financial flexibility and suggests that any future growth will require significant upfront investment that may not be immediately accretive to cash flow.
As reported in recent filings, Inogen's capital deployment has been largely constrained by its operating losses, with share repurchases totaling only $1.9 million in 2026Q1, a figure that appears modest given the company's stated goal of maintaining a stable and conservative balance sheet.
The limited scope of capital deployment suggests that management is prioritizing the preservation of its cash position over aggressive shareholder returns or large-scale acquisitions. This cautious approach appears prudent given the ongoing cash burn, but it also raises questions about the company's ability to pivot toward inorganic growth if organic efforts continue to falter.
Quick answers to the most common questions about buying INGN stock.
Inogen, Inc. (INGN) generated $-11.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Inogen, Inc. (INGN) reported negative free cash flow of $21.6M in 2025, indicating capital requirements exceeded cash from operations.
Inogen, Inc. (INGN) spent $10.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.